Online citations, reference lists, and bibliographies.

Imaging Features Of Carcinoid Tumors Of The Gastrointestinal Tract.

Dhakshina Ganeshan, Priya Bhosale, Thomas Yang, Vikas Kundra
Published 2013 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
OBJECTIVE Recent studies have provided a better understanding of the biologic behavior of gastrointestinal carcinoid tumors. This article focusing on imaging of gastrointestinal carcinoids will emphasize epidemiology, molecular biology, taxonomy, histopathology, and management. CONCLUSION Gastrointestinal carcinoids are a biologically heterogeneous group of tumors, with variable clinical presentation and biologic behavior. Imaging can play an important role in multidisciplinary identification and management of this disease.
This paper references
10.2214/AJR.10.4575
Hypervascular gastric masses: CT findings and clinical correlates.
Pamela T. Johnson (2010)
10.1210/jc.2004-1938
Whole-Body 11C-5-Hydroxytryptophan Positron Emission Tomography as a Universal Imaging Technique for Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and Computed Tomography
Håkan Örlefors (2005)
10.1053/j.gastro.2005.03.038
Current status of gastrointestinal carcinoids.
Irvin Mark Modlin (2005)
10.1001/archsurg.2010.10
Identification of unknown primary tumors in patients with neuroendocrine liver metastases.
Sam C Wang (2010)
10.1016/j.surg.2008.05.005
A proposed staging system for rectal carcinoid tumors based on an analysis of 4701 patients.
Christine S. Landry (2008)
10.1016/j.clinimag.2006.03.030
Gastrointestinal carcinoid tumors in rare locations: imaging findings.
Okkeş Ibrahim Karahan (2006)
10.1007/s00428-007-0452-1
TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system
Guido Rindi (2007)
10.1634/theoncologist.10-2-123
Metastatic carcinoid tumors: a clinical review.
Johanna Maria Zuetenhorst (2005)
10.1245/s10434-010-1006-3
Chromogranin A—Biological Function and Clinical Utility in Neuro Endocrine Tumor Disease
Irvin Mark Modlin (2010)
10.1159/000265561
Impact of Multiphase 68Ga-DOTATOC-PET/CT on Therapy Management in Patients with Neuroendocrine Tumors
Juri Ruf (2009)
10.1007/BF02629015
Carcinoid tumors of the gastrointestinal tract.
Mario R Baeza (1969)
lin e. or g by C ol or ad o St at e U ni ve rs ity o n 10 /0 2/ 13 f ro m I P ad dr es s
JL Cunningham (2013)
10.1016/s1040-1741(08)70208-2
Updated Population-Based Review of Carcinoid Tumors
Patrick j. Loehrer (2006)
Comparison of D
A Chiti (2013)
10.1007/978-1-4419-1005-9_45
Population-Based Study
Roselind Lieb (2012)
10.1080/02841859509173390
Midgut carcinoid tumours. CT appearance.
Eiji Sugimoto (1995)
10.1016/j.surg.2004.06.057
Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment.
J. Norton (2004)
10.1136/jcp.23.2.110
Elastic vascular sclerosis of mesenteric blood vessels in argentaffin carcinoma
P. Pietropaoli Anthony (1970)
10.1002/1097-0142(197403)33:3<798::AID-CNCR2820330327>3.0.CO;2-L
Carcinoid metastatic to the ovary. A clinicopathologic analysis of 35 cases
S. Robboy (1974)
10.2217/14796694.5.1.75
Update on nuclear medicine imaging of neuroendocrine tumors.
Stanley J. Goldsmith (2009)
10.1097/MPA.0b013e3181ebb2a5
The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Well-Differentiated Neuroendocrine Tumors of the Jejunum, Ileum, Appendix, and Cecum
J. Philip Boudreaux (2010)
10.1002/ijc.23529
Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study.
Manal M. Hassan (2008)
Karzinoide Tumoren des Dunndarms
Stefan Oberndorfer (1907)
lin e. or g by C ol or ad o St at e U ni ve rs ity o n 10 /0 2/ 13 f ro m I P ad dr es s
JL Cunningham (2013)
10.2214/ajr.164.2.7839976
Calcification and fibrosis in mesenteric carcinoid tumor: CT findings and pathologic correlation.
Linda Pantongrag-Brown (1995)
10.1200/JCO.2005.01.013
Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging.
C. Dromain (2005)
10.1097/01.sla.0000167862.52309.7d
Gastric Carcinoids: Biologic Behavior and Prognosis After Differentiated Treatment in Relation to Type
K. Borch (2005)
10.1002/1097-0142(19920515)69:10<2400::AID-CNCR2820691003>3.0.CO;2-Z
Incidence and mortality of carcinoids of the colon. Data from the Connecticut Tumor Registry.
Garth H. Ballantyne (1992)
10.1097/MPA.0b013e3181ec124e
The Pathologic Classification of Neuroendocrine Tumors: A Review of Nomenclature, Grading, and Staging Systems
David S Klimstra (2010)
10.1055/s-2004-814386
Treatment of multiple rectal carcinoids by endoscopic mucosal resection using a device for esophageal variceal ligation.
Yousuke Okamoto (2004)
Carcinoid tumors in the gastrointestinal tract--an analysis of 156 cases.
Hans Mårtensson (1983)
10.1007/s11605-008-0545-4
Carcinoid Tumour of the Appendix: An Analysis of 1,485 Consecutive Emergency Appendectomies
K. H. in’t Hof (2008)
10.2214/ajr.180.1.1800121
MR imaging of hepatic metastases caused by neuroendocrine tumors: comparing four techniques.
C. Dromain (2003)
10.1148/rg.1103035010
CT findings in sclerosing mesenteritis (panniculitis): spectrum of disease.
Karen M. Horton (2003)
10.1002/1097-0142(1971)28:4<990::aid-cncr2820280424>3.0.co;2-k
Pathologic analysis of carcinoids. Histologic reevaluation of 62 cases.
Jun Soga (1971)
10.1148/RG.276075027
Evaluation of submucosal lesions of the large intestine: part 1. Neoplasms.
P. Pickhardt (2007)
10.1016/j.amjsurg.2008.07.042
A proposed staging system for small bowel carcinoid tumors based on an analysis of 6,380 patients.
Christine S. Landry (2008)
10.1097/00000478-198605000-00007
Duodenal Carcinoids in Patients with and without Neurofibromatosis: A Comparative Study
Y. Dayal (1986)
10.1136/gutjnl-2011-300831
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
J. Ramage (2011)
10.1161/01.CIR.87.4.1188
Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients.
P. Pellikka (1993)
Imaging of NETs with PET radiopharmaceuticals.
V. Ambrosini (2010)
10.1067/j.cpsurg.2006.03.003
Carcinoid tumors.
Chandrajit P Raut (2006)
One hundred years after.
Fynn Rw (1959)
10.1002/cncr.25855
Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcome.
Henning Jann (2011)
10.1016/j.amjsurg.2010.04.016
Appendiceal carcinoid at a large tertiary center: pathologic findings and long-term follow-up evaluation.
R. L. Shapiro (2011)
10.2967/jnumed.110.083741
68Ga-DOTATOC PET/CT of Neuroendocrine Tumors: Spotlight on the CT Phases of a Triple-Phase Protocol
Juri Ruf (2011)
10.1002/cncr.11105
A 5-decade analysis of 13,715 carcinoid tumors.
Irvin Mark Modlin (2003)
10.2214/ajr.182.3.1820559
Carcinoid tumors of the small bowel: a multitechnique imaging approach.
K. Horton (2004)
WHO Classification of Tumours of the Digestive System
Fred T. Bosman (2010)
10.1002/jmri.1182
MRI of carcinoid tumors: spectrum of appearances in the gastrointestinal tract and liver.
Till R Bader (2001)
Goblet cell carcinoids of the appendix.
Berardi Rs (1988)
10.1007/s002689900026
Gastric Carcinoids and Neuroendocrine Carcinomas: Pathogenesis, Pathology, and Behavior
Guido Rindi (1996)
10.1677/ERC-07-0001
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study.
Maria Chiara Zatelli (2007)
10.1159/000080731
Epidemiology of Neuroendocrine Tumours
Babs G. Taal (2004)
Gastrointestinal carcinoid tumors.
Rudolf. Eller (1991)
10.1148/rg.233025134
Primary neoplasms of the appendix: radiologic spectrum of disease with pathologic correlation.
P. Pickhardt (2003)
10.1002/bjs.1800720715
Carcinoid tumours of the appendix.
J. Anderson (1985)
10.1210/jc.2007-2279
A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors.
M. Berna (2008)
10.1007/s10620-011-1773-0
CT-Enterography May Identify Small Bowel Tumors Not Detected by Capsule Endoscopy: Eight Years Experience at Mayo Clinic Rochester
Fayaz Ahmad Hakim (2011)
[Gastric neuroendocrine tumors].
O Louthan (2009)
10.1148/radiol.11110143
Prospective blinded comparison of wireless capsule endoscopy and multiphase CT enterography in obscure gastrointestinal bleeding.
James E. Huprich (2011)
10.1007/s002590050197
Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours
Stefan Dr. Adams (1997)
10.1016/j.jamcollsurg.2008.08.013
Proposed staging system for colon carcinoid tumors based on an analysis of 2,459 patients.
Christine S. Landry (2008)
10.1016/S0090-4295(02)02560-8
Metastatic renal carcinoid: case report and review of the literature.
Raanan Tal (2003)
10.1007/s00330-012-2615-y
Carcinoid tumours: predicting the location of the primary neoplasm based on the sites of metastases
Praveen Bhosale (2012)
10.1097/PAS.0b013e31824aba59
PDX-1, CDX-2, TTF-1, and CK7: A Reliable Immunohistochemical Panel for Pancreatic Neuroendocrine Neoplasms
Elaine S Chan (2012)
10.1097/MPA.0b013e3181ec1261
The NANETS Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Neuroendocrine Tumors (NETs): Well-Differentiated NETs of the Distal Colon and Rectum
Lowell B. Anthony (2010)
10.1200/JCO.2007.15.1126
Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.
Klaas Pieter Koopmans (2008)
10.2967/jnumed.109.069765
Functional Imaging of Neuroendocrine Tumors: A Head-to-Head Comparison of Somatostatin Receptor Scintigraphy, 123I-MIBG Scintigraphy, and 18F-FDG PET
Tina Binderup (2010)
10.1002/(SICI)1097-0142(19970415)79:8<1476::AID-CNCR5>3.0.CO;2-9
Atypical carcinoid of the esophagus: a case report and review of the literature.
G. M. Lindberg (1997)
Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography.
Håkan Orlefors (2005)
10.1053/J.GASTRO.2007.06.007
American Gastroenterological Association (AGA) Institute technical review on obscure gastrointestinal bleeding.
Gottumukkala S. Raju (2007)
10.1097/SLA.0b013e3181bdf8cf
Hepatic Metastases From Neuroendocrine Tumors With a “Thin Slice” Pathological Examination: They are Many More Than You Think …
D. Elias (2010)
10.3748/WJG.14.5245
Capsule endoscopy in neoplastic diseases.
M. Pennazio (2008)
10.1136/gut.33.9.1275
Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome.
Thérèse Lehy (1992)
10.1177/107327481101800207
A review of systemic and liver-directed therapies for metastatic neuroendocrine tumors of the gastroenteropancreatic tract.
Jonathan R Strosberg (2011)
10.1097/med.0b013e328320d845
Genetics and molecular pathology of neuroendocrine gastrointestinal and pancreatic tumors (gastroenteropancreatic neuroendocrine tumors).
Kjell E Oberg (2009)
10.1097/SLA.0b013e3181fd37e8
The Impact of 68Ga-DOTATOC Positron Emission Tomography/Computed Tomography on the Multimodal Management of Patients With Neuroendocrine Tumors
Andrea Frilling (2010)
10.1148/radiol.09090828
MR enteroclysis in the diagnosis of small-bowel neoplasms.
Stijn J. B. van Weyenberg (2010)
10.1016/S0016-5085(11)63626-3
The Risk of Metachronous Cancers in Patients With Small Intestinal Carcinoid Tumors
S. Amin (2011)
10.1245/ASO.2006.12.011
The Role of Genetic Markers— NAP1L1, MAGE-D2, and MTA1—in Defining Small-Intestinal Carcinoid Neoplasia
M. Kidd (2006)
10.1055/s-0030-1267204
A matter of the heart: myocardial metastases in neuroendocrine tumors.
H. Jann (2010)
10.1002/(SICI)1097-0142(19961015)78:8<1686::AID-CNCR8>3.0.CO;2-C
Peritoneal carcinomatosis in patients with digestive endocrine tumors.
B Vasseur (1996)
10.1200/JCO.2007.15.4377
One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.
James C. Yao (2008)
10.1245/s10434-008-0192-8
A Proposed Staging System for Gastric Carcinoid Tumors Based on an Analysis of 1,543 Patients
Christine S. Landry (2008)
10.1148/radiol.2373041863
Duodenal carcinoids: imaging features with clinical-pathologic comparison.
Angela D Levy (2005)
10.1148/radiol.2513081819
Small-bowel neoplasms: prospective evaluation of MR enteroclysis.
Gabriele Masselli (2009)
10.1586/egh.12.15
Chromogranin A: a sensitive biomarker for the detection and post-treatment monitoring of gastroenteropancreatic neuroendocrine tumors
Simron Singh (2012)
Medical progress : Carcinoid tumors
Matthew H. Kulke (1999)
10.1102/1470-7330.2010.9007
Use of molecular targeted agents for the diagnosis, staging and therapy of neuroendocrine malignancy
R. J. Hicks (2010)
10.1002/cncr.20659
Carcinoid metastasis to the brain.
R. Hlatký (2004)
Comparison of D
A Chiti (2013)
Clinical features, diagnosis, and localization of carcinoid tumors and their management.
Aaron I Vinik (1989)
10.1530/eje.0.1510015
Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours.
Gregory A. Kaltsas (2004)
10.1023/A:1008215730767
Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center.
Eva Tiensuu Janson (1997)
10.1097/PAS.0b013e31818d7d8b
Immunohistochemical Staining for CDX-2, PDX-1, NESP-55, and TTF-1 Can Help Distinguish Gastrointestinal Carcinoid Tumors From Pancreatic Endocrine and Pulmonary Carcinoid Tumors
Amitabh Srivastava (2009)
10.1097/00004728-199505000-00012
Midgut Carcinoid Tumors: CT Findings and Biochemical Profiles
Pamela K. Woodard (1995)
10.1148/rg.263055162
CT enterography as a diagnostic tool in evaluating small bowel disorders: review of clinical experience with over 700 cases.
Scott R Paulsen (2006)
Biochemical diagnosis of neuroendocrine GEP tumor.
Kjell Oberg (1997)
10.1007/s002590050314
Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours
A. Chiti (1998)
10.1007/s10620-007-0110-0
Double Balloon Enteroscopy Detects Small Bowel Mass Lesions Missed by Capsule Endoscopy
Andrew Peter Ross (2007)
10.1016/j.amjsurg.2011.12.010
Laparoscopic surgical exploration is an effective strategy for locating occult primary neuroendocrine tumors.
Kristen P. Massimino (2012)
10.1002/bjs.1800770919
Primary gastric carcinoids: a view on management.
M. Davies (1990)
10.4061/2011/404916
Selective Internal Radiation Therapy for Gastrointestinal Neuroendocrine Tumour Liver Metastases: A New and Effective Modality for Treatment
Harshal Rajekar (2011)
10.2214/ajr.143.3.581
Computed tomography of abdominal carcinoid tumors.
Daniel Picus (1984)
10.1007/s10620-011-1854-0
Novel Medical Therapies of Recurrent and Metastatic Gastroenteropancreatic Neuroendocrine Tumors
M. D. Miljković (2011)
10.1016/j.bpg.2005.05.009
Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatment.
Katrin M. Hoffmann (2005)
Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis.
Geoffrey Thompson (1985)
10.1097/00006254-197501000-00021
Carcinoid metastatic to the ovary. A clinocopathologic analysis of 35 cases.
Stanley J. Robboy (1974)
10.2214/AJR.09.2760
Value of CT enteroclysis in suspected small-bowel carcinoid tumors.
Imane Kamaoui (2010)
10.1055/s-0030-1255564
Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?
Hans Scheruebl (2010)
10.1002/1097-0142(197508)36:2<560::AID-CNCR2820360235>3.0.CO;2-4
Carcinoid tumors. An analysis of 2,837 cases.
J. David Godwin (1975)
10.1002/gcc.20834
Common pathogenetic mechanism involving human chromosome 18 in familial and sporadic ileal carcinoid tumors.
Janet L Cunningham (2011)
10.1155/2012/819193
A Multimodal Approach to the Management of Neuroendocrine Tumour Liver Metastases
Ron Basuroy (2012)
10.1016/j.gie.2009.09.031
Indications and detection, completion, and retention rates of small-bowel capsule endoscopy: a systematic review.
Zhuan Liao (2010)
10.1007/BF00181765
Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients
Eric Paul Krenning (2004)
10.1159/000326237
Follow-Up of Known Carcinoid Liver Metastases: Is Respiratory-Gated T2 Fast Spin-Echo Enough?
Priya Bhosale (2011)
10.1148/rg.271065169
From the archives of the AFIP: Gastrointestinal carcinoids: imaging features with clinicopathologic comparison.
Angela D Levy (2007)
10.1007/s002689900023
Carcinoid Tumors: Imaging Procedures and Interventional Radiology
S. Wallace (1996)
10.1159/000225952
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Follow-Up and Documentation
R. Arnold (2009)
10.4158/EP08318.ORR1
Metabolic and receptor imaging in patients with neuroendocrine tumors: comparison of fludeoxyglucose-positron emission tomography and computed tomography with indium in 111 pentetreotide.
Martina Zalom (2009)
10.1056/NEJM198712313172704
Carcinoid tumor of the appendix: treatment and prognosis.
C. Moertel (1987)
10.1002/cncr.20939
Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases.
J. Soga (2005)



This paper is referenced by
10.1097/MPA.0000000000000920
Magnetic Resonance Imaging of Neuroendocrine Tumor Hepatic Metastases: Does Hepatobiliary Phase Imaging Improve Lesion Conspicuity and Interobserver Agreement of Lesion Measurements?
Brian Morse (2017)
10.1007/s00261-019-01913-8
The “spoke wheel” sign in mesenteric carcinoid
Dario Giambelluca (2019)
10.1007/s00330-017-4764-5
Poorly-differentiated colorectal neuroendocrine tumour: CT differentiation from well-differentiated neuroendocrine tumour and poorly-differentiated adenocarcinomas
Ji Hee Kang (2017)
10.2169/internalmedicine.1700-18
Usefulness of Capsule Endoscopy and Double-balloon Enteroscopy for the Diagnosis of Multiple Carcinoid Tumors in the Small Intestine: Case Reports and a Literature Review
Kentaro Tominaga (2019)
10.1007/978-3-319-98902-0_30
Managing Uncommon Rectal Tumors
E. B. Sneider (2019)
10.1053/j.ro.2016.02.008
Somatostatin Receptor Scintigraphy of Neuroendocrine Tumors of the Abdomen and Pelvis.
Bruce Mahoney (2016)
Gastrointestinal and pancreatic neuroendocrine tumours and carcinomas; a review of rare tumour type.
Ayesha Siddiqa (2019)
10.1016/j.ctrv.2016.05.003
Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensus.
S. Singh (2016)
10.5603/EP.2017.0018
Neuroendocrine neoplasms of the small intestine and appendix - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).
T. Bednarczuk (2017)
10.7759/cureus.7186
Carcinoid Syndrome: A Review
Ajay K. Gade (2020)
UNBS 5162 inhibits the proliferation of esophageal cancer squamous cells via the PI 3 K / AKT signaling pathway
He Dan (2017)
10.15557/JoU.2015.0024
Mesenteric changes in an ultrasound examination can facilitate the diagnosis of neuroendocrine tumors of the small intestine
Andrzej Smereczyński (2015)
10.4143/crt.2014.183
The Role of Plasma Chromogranin A as Assessment of Treatment Response in Non-functioning Gastroenteropancreatic Neuroendocrine Tumors
Moonjin Kim (2016)
10.3748/wjg.v23.i45.8090
Midgut neuroendocrine tumor presenting with acute intestinal ischemia
Ioannis Mantzoros (2017)
Rectal lesions on MRI: Beyond adenocarcinoma
Yiken Karelys Ng Wong (2015)
10.1007/s00261-014-0113-1
De-Misty-fying the mesentery: an algorithmic approach to neoplastic and non-neoplastic mesenteric abnormalities
Myles T. Taffel (2014)
10.12809/hkjr1716935
Magnetic Resonance Imaging for Rectal Submucosal Tumours
Bty Yuen (2017)
10.1292/jvms.19-0101
Dual-phase computed tomography angiography of intestinal carcinoid tumor as a lead point for cecocolic intussusception in a dog
Sooa Yoon (2019)
10.21037/33236
Disorders of neural crest derivates in oncoradiological practice
Tamás Papp (2019)
10.1590/0100-3984.2014.47.4qd
Which is your diagnosis?
Pedro José de Santana Júnior (2014)
10.1007/s11154-017-9437-9
Management of neuroendocrine tumors of unknown primary
K. Alexandraki (2017)
10.1007/s40134-017-0227-7
Gastrointestinal Imaging: Emerging Role of Dual-Energy Computed Tomography
Ismail Tawakol Ali (2017)
10.1007/s11547-018-0946-8
Diagnostic imaging of gastrointestinal neuroendocrine tumours (GI-NETs): relationship between MDCT features and 2010 WHO classification
Giulia Grazzini (2018)
Midgut Carcinoid Tumor in an Elderly Female: A Rare Case Report
Mamindapalli Ravi Shanker (2015)
10.1159/000367850
The Status of Neuroendocrine Tumor Imaging: From Darkness to Light?
L. Bodei (2014)
10.1016/j.ecl.2017.04.008
Imaging of Neuroendocrine Tumors: Indications, Interpretations, Limits, and Pitfalls.
Run Yu (2017)
CT Enterography Evaluation of Small Intestine Neuroendocrine Tumours and Correlation with 68 Ga-DOTA-NOC PET/CT Findings
Diogo Ribeiro da Fonseca (2017)
10.1097/TA.0000000000001378
Predicting appendiceal tumors among patients with appendicitis
Tyler J. Loftus (2017)
10.1080/20905068.2020.1767529
Beyond the commonest: right lower quadrant abdominal pain is not always appendicitis
Mahmoud K Khedher Agha (2020)
10.1080/16089677.2020.1722402
Midgut neuroendocrine tumour presenting as orbital metastases
Helen Hoenck (2020)
10.1186/s40792-020-0800-9
Multiple liver metastases originating from synchronous double cancer of neuroendocrine tumor and rectal cancer: a case report
Sachie Omori (2020)
10.1007/s00261-019-01945-0
CT detection of primary and metastatic ileal carcinoid tumor: rates of missed findings and associated delay in clinical diagnosis
Akshya Gupta (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar